Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ghanekar, Anand ^a,b,c   Ahmed, Sharif ^a   Chen, Kui ^a   Adeyi, Oyedele ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angiogenesis; Cancer stem cell; CD31; CD34; Endothelial cell; Hepatocellular carcinoma; Liver transplantation; Recurrence; Tumor initiating cell; Xenograft

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; CD34 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; TUMOR CELL; TUMOR XENOGRAFT; X CHROMOSOME; Y CHROMOSOME;

ANIMALS; ANTIGENS, CD31; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HETEROGRAFTS; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84885490306     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-485     Document Type: Article

References (21)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
2. Ping YF, Bian XW. Concise review: contribution of cancer stem cells to neovascularization. Stem Cells 2011, 29(6):888-894. 10.1002/stem.650, 21557392.
3. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468(7325):824-828. 10.1038/nature09557, 21102434.
4. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468(7325):829-833. 10.1038/nature09624, 21102433.
5. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236. 10.1002/hep.20933, 16250051.
7. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359(4):378-390. 10.1056/NEJMoa0708857, 18650514.
8. Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol 2013, 7(3):269-279. 10.1586/egh.13.3, 23445236.
9. Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006, 242(2):151-167. 10.1016/j.canlet.2006.01.008, 16564617.
10. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132(7):2542-2556. 10.1053/j.gastro.2007.04.025, 17570225.
11. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136(3):1012-1024. 10.1053/j.gastro.2008.12.004, 2828822, 19150350.
12. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13(2):153-166. 10.1016/j.ccr.2008.01.013, 18242515.
13. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011, 9(1):50-63. 10.1016/j.stem.2011.06.005, 21726833.
14. Chen K, Ahmed S, Adeyi O, Dick JE, Ghanekar A. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus. PLoS One 2012, 7(6):e39294. 10.1371/journal.pone.0039294, 3377749, 22723990.
15. Lafreniere R, Rosenberg SA. A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst 1986, 76(2):309-322.
16. Ahmed S, Zair M, Chen K, Iu M, He F, Adeyi O, Cleary S, Ghanekar A. Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice. J Vis Exp 2013, 79:e50544.
17. DuBay D, Sandroussi C, Sandhu L, Cleary S, Guba M, Cattral MS, McGilvray I, Ghanekar A, Selzner M, Greig PD, et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 2011, 253(1):166-172. 10.1097/SLA.0b013e31820508f1, 21294289.
18. Cui S, Hano H, Sakata A, Harada T, Liu T, Takai S, Ushigome S. Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma. Pathol Int 1996, 46(10):751-756. 10.1111/j.1440-1827.1996.tb03544.x, 8916144.
19. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317(5836):337. 10.1126/science.1142596, 17641192.
20. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000, 23(2):101-113. 10.2165/00002018-200023020-00002, 10945373.
21. Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol 2012, 9(9):498-509. 10.1038/nrclinonc.2012.120, 22850752.